Introduction The pharmaceutical industry occupies a central position in the global healthcare narrative, often facing intense scrutiny regarding the pricing of therapeutic agents. While concerns about accessibility are valid, it is essential to recognize that biopharma innovation serves as a powerful deflationary force in the long run. By shifting the paradigm from symptom management to […]